China Medical System Holdings Statistics
Want to see HK:0867 full AI Analyst Report?
China Medical System Holdings (0867) Stock Statistics & Valuation Metrics
Total Valuation
China Medical System Holdings has a market cap or net worth of HKD 24.18B. The enterprise value is HKD 19.40B.
- Market Cap
- HKD 24.18B
- Enterprise Value
- HKD 19.40B
Share Statistics
China Medical System Holdings has 2,439,528,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,439,528,600
- Owned by Insiders
- ―
- Owned by Institutions
- 9.36%
Financial Efficiency
China Medical System Holdings’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 5.89%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 5.89%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 1.28M
- Profits Per Employee
- 232.10K
- Employee Count
- 6,415
- Asset Turnover
- 0.43
- Inventory Turnover
- 2.91
Valuation Ratios
The current PE Ratio of China Medical System Holdings is 13.57. China Medical System Holdings’s PEG ratio is -1.54.
- PE Ratio
- 13.57
- PS Ratio
- 2.37
- PB Ratio
- 1.13
- Price to FCF
- 41.62
- Price to Operating Cash Flow
- 19.71
- PEG Ratio
- -1.54
Income Statement
In the last 12 months, China Medical System Holdings had revenue of 8.21B and earned 1.49B in profits. Earnings per share was 0.62.
- Revenue
- 8.21B
- Gross Profit
- 5.87B
- Operating Income
- 1.58B
- Pretax Income
- 2.10B
- Net Income
- 1.49B
- EBITDA
- 1.85B
- Earnings Per Share (EPS)
- 0.62
Cash Flow
In the last 12 months, operating cash flow was 1.03B and capital expenditures -540.91M, giving a free cash flow of 491.88M billion.
- Operating Cash Flow
- 1.03B
- Free Cash Flow
- 491.88M
- Free Cash Flow per Share
- 0.20
Dividends & Yields
China Medical System Holdings pays an annual dividend of HKD 0.16, resulting in a dividend yield of 3.47%
- Dividend Per Share
- HKD 0.16
- Dividend Yield
- 3.47%
- Payout Ratio
- 45.48%
- Free Cash Flow Yield
- 2.40%
- Earnings Yield
- 7.47%
Stock Price Statistics
- Beta
- 0.87
- 52-Week Price Change
- -29.42%
- 50-Day Moving Average
- 10.49
- 200-Day Moving Average
- 11.77
- Relative Strength Index (RSI)
- 39.26
- Average Volume (3m)
- 5.00M
Important Dates
China Medical System Holdings upcoming earnings date is Mar 16, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- Mar 16, 2027
- Ex-Dividend Date
- Apr 27, 2026
Financial Position
China Medical System Holdings as a current ratio of 6.33, with Debt / Equity ratio of 3.97%
- Current Ratio
- 6.33
- Quick Ratio
- 5.78
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -1.09
- Interest Coverage Ratio
- 77.77
Taxes
In the past 12 months, China Medical System Holdings has paid 659.78M in taxes.
- Income Tax
- 659.78M
- Effective Tax Rate
- 0.31
Enterprise Valuation
China Medical System Holdings EV to EBITDA ratio is 9.38, with an EV/FCF ratio of 38.18.
- EV to Sales
- 2.17
- EV to EBITDA
- 9.38
- EV to Free Cash Flow
- 38.18
- EV to Operating Cash Flow
- 18.18
Balance Sheet
China Medical System Holdings has HKD 5.75B in cash and marketable securities with HKD 882.77M in debt, giving a net cash position of HKD 4.87B billion.
- Cash & Marketable Securities
- HKD 5.75B
- Total Debt
- HKD 882.77M
- Net Cash
- HKD 4.87B
- Net Cash Per Share
- HKD 2.00
- Tangible Book Value Per Share
- HKD 5.17
Margins
Gross margin is 71.18%, with operating margin of 19.93%, and net profit margin of 17.58%.
- Gross Margin
- 71.18%
- Operating Margin
- 19.93%
- Pretax Margin
- 24.66%
- Net Profit Margin
- 17.58%
- EBITDA Margin
- 23.15%
- EBIT Margin
- 19.93%
Analyst Forecast
The average price target for China Medical System Holdings is HKD 17.81, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- HKD 17.81
- Price Target Upside
- 79.76% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- 14.80%
- EPS Growth Forecast
- -2.88%
Scores
- Smart Score
- 5
- AI Score
- 61

